Novo Nordisk’s obesity drug isn’t even available in the UK yet, but the government has already launched a pilot programme that could see access to the drug expanded throug
Researchers in the UK say Grail’s blood test for more than 50 different types of cancer has shown promise in a trial involving thousands of people with suspected cancer sy
For over a decade, Health Union has regularly fielded condition-specific In America surveys within its growing portfolio of online health communities.
Pfizer’s Vydura has become the first oral CGRP antagonist recommended for routine use by the NHS to prevent episodic migraine attacks, after being rejected earlier this ye
A new clinical study has found that a wearable device developed by PD Neurotechnology was 95% accurate in detecting and assessing motor symptoms of Parkinson’s disease, wh
Editor's Picks
